Abstract
Background and Aims: Obstructive sleep apnea (OSA) is associated with increased risk of cardiovascular disease. Resistin is recognized as a potent proinflammatory cytokine that is able to influence atherosclerotic plaque progression through several mechanisms. Resistin facilitates formation of foam cells through upregulation of CD36 scavenger receptor and increased uptake of oxidized low density lipoprotein. Its proinflammatory effects are mainly exerted via adenylate cyclase-associated protein 1 (CAP1). The aim of this study was to investigate if resistin, CAP1 and CD36 mRNA levels in peripheral blood mononuclear cells (PBMCs) are associated with hypercholesterolemia in patients with obstructive sleep apnea.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
